ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).
Is the worst over? Catalent touts GLP-1 and gene therapy business as it sticks to financial guidance
Catalent’s financial health appears to be on the mend thanks to specific segments of its manufacturing business, but the CDMO still has a long road